Coronial
NSWcommunity

Inquest into the deaths of Christopher SALIB, Nathan ATTARD and Shamsad AKHTAR

Deceased

Christopher Salib, Nathan Attard, Shamsad Akhtar

Coroner

Decision ofDeputy State Coroner Forbes

Date of death

2011-02-06, 2012-03-20, 2011-06-06

Finding date

2014-06-27

Cause of death

Christopher Salib: ischaemic heart disease with multiple prescription drug toxicity as contributing cause; Nathan Attard: unintentional consequences of ingesting lethal combination of prescription drugs; Shamsad Akhtar: unintentional consequences of ingesting lethal combination of prescription drugs

AI-generated summary

This landmark inquest examined three deaths involving prescription drug toxicity: Christopher Salib (24, ischaemic heart disease with drug toxicity), Nathan Attard (34, multi-drug toxicity), and Shamsad Akhtar (35, multi-drug toxicity). All died from lethal combinations of benzodiazepines, opioids, and other prescription medications obtained through multiple doctors ('doctor shopping'). Key failures included: lack of real-time prescribing systems preventing visibility of multiple dispensing; inadequate communication between GPs and pharmacists; prescribing of benzodiazepines and opioids to known substance-dependent patients; failure to consult psychiatrists for long-term psychiatric medication; emergency departments lacking access to full patient histories; and pharmacy failures to maintain notes or refuse dangerous dispensing. The coroner concluded existing regulation (Prescription Shopping Program, PBS restrictions) had no meaningful impact. Major recommendations include implementing real-time electronic prescription monitoring including benzodiazepines, mandatory consultation with psychiatrists for long-term psychiatric medications, enhanced GP education on addictive drugs, and improved coordination between health professionals.

AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.

Specialties

general practiceemergency medicinepsychiatryaddiction medicinepharmacypain medicine

Error types

diagnosticmedicationcommunicationsystemdelay

Drugs involved

alprazolamparoxetineziprasidonetramadolparacetamol/codeineoxycodonediazepamcodeine phosphateamitriptylinemorphine sulphatebenzodiazepinesmirtazapinezolpidemtemazepamoxazepamquetiapinebuprenorphinemeloxicamdiclofenacibuprofenparacetamol/codeineparacetamol/codeine/doxylaminenitrazepammetoclopramideerythromycindoxylamine succinatetadalafildextropropoxypheneserapaxnorspan patcheletriptan

Clinical conditions

substance use disorderbenzodiazepine dependenceopioid dependenceprescription drug misuseschizophreniadepressionanxietyinsomniachronic painback painmigraineischaemic heart diseaserespiratory depressionserotonin syndromealcohol use disorder

Contributing factors

  • doctor shopping - seeing multiple doctors to obtain excessive medications
  • lack of real-time prescription monitoring system
  • failure to communicate between prescribers
  • failure to communicate between prescribers and pharmacists
  • prescribing benzodiazepines long-term despite contra-indications and addiction risk
  • prescribing opioids to substance-dependent patients
  • prescribing psychiatric medications without psychiatric consultation
  • emergency department lack of access to full patient history
  • fragmentation of care across multiple medical services
  • inadequate assessment before initiating addictive medications
  • pharmacy failure to refuse dangerous dispensing
  • pharmacy failure to maintain clinical notes
  • inappropriate combination prescribing (tramadol with serotonergic antidepressants, benzodiazepines with opioids)
  • inadequate medical record keeping by doctors
  • false claims of lost prescriptions and trips not followed up
  • escalating medication doses without clinical justification

Coroner's recommendations

  1. Move all benzodiazepines to Schedule 8 of the Uniform Scheduling of Medicines and Poisons
  2. Implement real-time web-based prescription monitoring program available to pharmacists and GPs within 12 months recording all Schedule 8 dispensing and providing real-time information
  3. Include all benzodiazepines in the real-time prescription monitoring system
  4. Educate pharmacists and GPs on reporting inappropriate prescribing and identification methods
  5. Require doctors to verify prescribing history before commencing Schedule 8 drugs or benzodiazepines; if not practicable, limit supply to essential amounts until history obtained
  6. Expand restrictions on Schedule 8 drug prescribing to include restricted drugs of dependence
  7. Pharmacy Guild develop de-identified case studies on prescription misuse for continuing education
  8. Pharmacy Guild, Pharmaceutical Society and RACGP collaborate on promoting staged supply, supervised administration, and education modules on responding to suspected medication misuse
  9. RACGP develop 1-2 page clinical guideline covering chronic non-cancer pain management, benzodiazepine prescription, opioid prescription, private and repeat prescription appropriateness, and available resources
  10. RACGP develop clinical governance framework for General Practices addressing prescription drug abuse
  11. RACGP and NCIS liaise on sharing information about prescription medication-linked deaths
  12. RACGP require all GPs prescribing Schedule 8 or benzodiazepines to attend skills training within 3 years on pain management, drug dependency, and opioid/benzodiazepine prescribing
  13. Include education module addressing information sharing and legal constraints in continuing professional development
  14. RACGP establish local forums for GPs, pharmacists and specialists to identify doctor shopping patterns and establish communication channels
  15. Medicare work with Pharmaceutical Society and Pharmacy Guild to facilitate pharmacist access to prescription hotline
  16. Make registration under Prescription Shopping Program compulsory for all medical prescribers
  17. Review efficacy of Prescription Shopping Program and improve prompt identification of medication abuse
  18. Commonwealth and NSW Health require GP consultation with psychiatrist before prescribing long-term anti-depressant or anti-psychotic medications except in exceptional circumstances
Full text

Source and disclaimer

This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.

Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.

Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.